Dashboard
Curated content
Companies
Funding rounds
Exits
Investors
Accelerators
Matching tool
Investment heatmap
News
Companies
ViaCyte
Team
Team
Save
ViaCyte
First in Kind Cellular Treatment for Diabetes.
Learn more
Launch date
1999
Employees
51-200 people
Market cap
-
Enterprise valuation
€291m
(Public information from Jul 2022)
San Diego California (HQ)
http://viacyte.com
https://twitter.com/viacyte
https://www.facebook.com/viacyte
https://www.linkedin.com/company/viacyte-formerly-novocell-
B2B
manufacturing
health
biotechnology
pharmaceutical
hard tech
biotechnology
horizon europe
biotech and pharma
risk management
diabetes
personal health
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (122)
Authorizing premium user...